信息搜索
信息关键字：药
  

共有4382条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220]

·上海医药将成首家A+H大型医药公司2011-4-18 19:32:43
·红日药业年报点评：中药配方颗粒形势喜人2011-4-18 18:42:24
·康缘药业：收入快速增长 研发提供成长动力2011-4-18 18:21:33
·医药行业：医药板块出现回暖迹象2011-4-18 18:05:12
·康缘药业：收入快速增长 研发提供成长动力2011-4-18 17:02:17
·食品药品监管局局长邵明立会见美国犹他州州长2011-4-18 14:07:12
·双鹭药业:内外并举,重拾高增长2011-4-18 10:42:43
·拷问药品业生态圈：尼美舒利“死亡”之谜2011-4-17 13:58:49
·布局高成长医药股2011-4-17 11:07:35
·杜猛：市场向下空间不大 看好太阳能节能及医药股2011-4-16 16:05:49
·国家中医药发展论坛第二届学术研讨会在广州召开2011-4-16 10:44:11
·红日药业：上调至“推荐”评级2011-4-16 10:23:16
·双鹭药业：维持对公司的“推荐”评级2011-4-16 10:19:04
·兰州生物医药产业“十二五”将爆发式增长2011-4-16 3:54:48
·康缘药业：成本压力犹存 股权激励影响短期表现2011-4-15 20:07:11
·食品药品监管局要求做好中药注射剂安全性再评价2011-4-15 18:52:06
·精华制药：政府补贴增厚业绩 中药增长缓步恢复2011-4-15 18:52:02
·双鹭药业：中报净利润预增50%-80%2011-4-15 18:47:50
·红日药业：依托中药颗粒业绩有望爆发2011-4-15 18:22:48
·舒泰神：生物制药后起之秀 快速成长可期2011-4-15 18:14:24

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220]